These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 27159394

  • 1. Cre-inducible human CD59 mediates rapid cell ablation after intermedilysin administration.
    Feng D, Dai S, Liu F, Ohtake Y, Zhou Z, Wang H, Zhang Y, Kearns A, Peng X, Zhu F, Hayat U, Li M, He Y, Xu M, Zhao C, Cheng M, Zhang L, Wang H, Yang X, Ju C, Bryda EC, Gordon J, Khalili K, Hu W, Li S, Qin X, Gao B.
    J Clin Invest; 2016 Jun 01; 126(6):2321-33. PubMed ID: 27159394
    [Abstract] [Full Text] [Related]

  • 2. Rapid conditional targeted ablation of cells expressing human CD59 in transgenic mice by intermedilysin.
    Hu W, Ferris SP, Tweten RK, Wu G, Radaeva S, Gao B, Bronson RT, Halperin JA, Qin X.
    Nat Med; 2008 Jan 01; 14(1):98-103. PubMed ID: 18157141
    [Abstract] [Full Text] [Related]

  • 3. Mapping the intermedilysin-human CD59 receptor interface reveals a deep correspondence with the binding site on CD59 for complement binding proteins C8alpha and C9.
    Wickham SE, Hotze EM, Farrand AJ, Polekhina G, Nero TL, Tomlinson S, Parker MW, Tweten RK.
    J Biol Chem; 2011 Jun 10; 286(23):20952-62. PubMed ID: 21507937
    [Abstract] [Full Text] [Related]

  • 4. Rapid conditional targeted ablation model for hemolytic anemia in the rat.
    Hanson MM, Liu F, Dai S, Kearns A, Qin X, Bryda EC.
    Physiol Genomics; 2016 Aug 01; 48(8):626-32. PubMed ID: 27368711
    [Abstract] [Full Text] [Related]

  • 5. Structural basis for recognition of the pore-forming toxin intermedilysin by human complement receptor CD59.
    Johnson S, Brooks NJ, Smith RA, Lea SM, Bubeck D.
    Cell Rep; 2013 May 30; 3(5):1369-77. PubMed ID: 23665225
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis.
    LaChapelle S, Tweten RK, Hotze EM.
    J Biol Chem; 2009 May 08; 284(19):12719-26. PubMed ID: 19293153
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The cytolytic activity of vaginolysin strictly depends on cholesterol and is potentiated by human CD59.
    Zilnyte M, Venclovas Č, Zvirbliene A, Pleckaityte M.
    Toxins (Basel); 2015 Jan 13; 7(1):110-28. PubMed ID: 25590277
    [Abstract] [Full Text] [Related]

  • 11. Human CD59 is a receptor for the cholesterol-dependent cytolysin intermedilysin.
    Giddings KS, Zhao J, Sims PJ, Tweten RK.
    Nat Struct Mol Biol; 2004 Dec 13; 11(12):1173-8. PubMed ID: 15543155
    [Abstract] [Full Text] [Related]

  • 12. Intermedilysin cytolytic activity depends on heparan sulfates and membrane composition.
    Drabavicius G, Daelemans D.
    PLoS Genet; 2021 Feb 13; 17(2):e1009387. PubMed ID: 33577603
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Adipocyte Death Preferentially Induces Liver Injury and Inflammation Through the Activation of Chemokine (C-C Motif) Receptor 2-Positive Macrophages and Lipolysis.
    Kim SJ, Feng D, Guillot A, Dai S, Liu F, Hwang S, Parker R, Seo W, He Y, Godlewski G, Jeong WI, Lin Y, Qin X, Kunos G, Gao B.
    Hepatology; 2019 May 13; 69(5):1965-1982. PubMed ID: 30681731
    [Abstract] [Full Text] [Related]

  • 18. Positive- and Negative-Control Pathways by Blood Components for Intermedilysin Production in Streptococcus intermedius.
    Tomoyasu T, Yamasaki T, Chiba S, Kusaka S, Tabata A, Whiley RA, Nagamune H.
    Infect Immun; 2017 Sep 13; 85(9):. PubMed ID: 28607101
    [Abstract] [Full Text] [Related]

  • 19. Protective effects of different combinations of human MCP, DAF, and CD59 on complement-dependent cytolysis in NIH 3T3 cells.
    Yang X, Deng J, Jiang Z, Liao DJ, Jiang H.
    Exp Clin Transplant; 2012 Feb 13; 10(1):49-54. PubMed ID: 22309420
    [Abstract] [Full Text] [Related]

  • 20. A distinctive histidine residue is essential for in vivo glycation-inactivation of human CD59 transgenically expressed in mice erythrocytes: Implications for human diabetes complications.
    Sahoo R, Ghosh P, Chorev M, Halperin JA.
    Am J Hematol; 2017 Nov 13; 92(11):1198-1203. PubMed ID: 28815695
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.